| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 1 | 0 | 0 | 1 |
| Genome polyprotein | 0 | 1 | 1 | 2 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| thioredoxin reductase | 3 | 0 | 0 | 3 |
| ATAD5 protein, partial | 1 | 0 | 0 | 1 |
| Fumarate hydratase | 1 | 0 | 0 | 1 |
| GLS protein | 1 | 0 | 0 | 1 |
| TDP1 protein | 6 | 0 | 0 | 6 |
| AR protein | 3 | 0 | 0 | 3 |
| regulator of G-protein signaling 4 | 1 | 0 | 0 | 1 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 3 | 0 | 0 | 3 |
| glucocorticoid receptor [Homo sapiens] | 2 | 0 | 0 | 2 |
| pregnane X nuclear receptor | 6 | 0 | 0 | 6 |
| estrogen nuclear receptor alpha | 6 | 0 | 0 | 6 |
| G | 2 | 0 | 0 | 2 |
| polyprotein | 1 | 0 | 0 | 1 |
| peroxisome proliferator activated receptor gamma | 5 | 0 | 0 | 5 |
| euchromatic histone-lysine N-methyltransferase 2 | 7 | 0 | 0 | 7 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 4 | 0 | 0 | 4 |
| D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
| vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
| chromobox protein homolog 1 | 3 | 0 | 0 | 3 |
| thyroid hormone receptor beta isoform 2 | 3 | 0 | 0 | 3 |
| serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 3 | 0 | 0 | 3 |
| 5-hydroxytryptamine receptor 4 | 0 | 4 | 0 | 4 |
| Interferon beta | 3 | 0 | 0 | 3 |
| HLA class I histocompatibility antigen, B alpha chain | 2 | 0 | 0 | 2 |
| Cellular tumor antigen p53 | 3 | 0 | 0 | 3 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
| Beta-1 adrenergic receptor | 0 | 4 | 1 | 5 |
| Cytochrome P450 3A4 | 0 | 4 | 0 | 5 |
| 5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 3 | 2 | 6 |
| D(2) dopamine receptor | 0 | 3 | 2 | 5 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Alpha-2B adrenergic receptor | 0 | 2 | 1 | 4 |
| Alpha-2C adrenergic receptor | 0 | 3 | 2 | 6 |
| D | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 4 | 1 | 6 |
| Alpha-2B adrenergic receptor | 0 | 1 | 1 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 0 | 3 | 1 | 4 |
| Alpha-2C adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-2A adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-1D adrenergic receptor | 0 | 2 | 1 | 4 |
| D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 4 | 2 | 6 |
| 5-hydroxytryptamine receptor 2C | 0 | 4 | 2 | 6 |
| 5-hydroxytryptamine receptor 1B | 0 | 4 | 0 | 4 |
| D(4) dopamine receptor | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 2 | 0 | 2 |
| Alpha-synuclein | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 4 | 1 | 5 |
| 5-hydroxytryptamine receptor 6 | 0 | 4 | 1 | 5 |
| D(2) dopamine receptor | 0 | 1 | 1 | 2 |
| Inositol hexakisphosphate kinase 1 | 2 | 0 | 0 | 2 |
| ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
| Ataxin-2 | 3 | 0 | 0 | 3 |
| cytochrome P450 2C9, partial | 2 | 0 | 0 | 2 |
| ATP-dependent phosphofructokinase | 1 | 0 | 0 | 1 |
| Chain A, Vitamin D Nuclear Receptor | 0 | 0 | 1 | 1 |
| Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
| Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
| Vitamin D3 receptor | 0 | 0 | 1 | 1 |
| USP1 protein, partial | 3 | 0 | 0 | 3 |
| PPM1D protein | 1 | 0 | 0 | 1 |
| Microtubule-associated protein tau | 1 | 0 | 0 | 1 |
| thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
| mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
| nuclear receptor ROR-gamma isoform 1 | 2 | 0 | 0 | 2 |
| geminin | 3 | 0 | 0 | 3 |
| peripheral myelin protein 22 | 2 | 0 | 0 | 2 |
| ATP-binding cassette sub-family C member 3 | 0 | 4 | 0 | 4 |
| Multidrug resistance-associated protein 4 | 0 | 4 | 0 | 4 |
| Bile salt export pump | 0 | 5 | 0 | 5 |
| Vitamin D-binding protein | 0 | 0 | 1 | 1 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 2 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
| Vitamin D3 receptor | 0 | 1 | 2 | 4 |
| Cytochrome P450 2C9 | 0 | 2 | 0 | 3 |
| Vitamin D3 receptor | 0 | 1 | 1 | 3 |
| Retinoic acid receptor RXR-alpha | 0 | 0 | 3 | 3 |
| Cytochrome P450 2C19 | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 0 | 1 | 1 |
| Vitamin D3 receptor | 0 | 0 | 1 | 1 |
| 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 0 | 1 | 1 |
| Vitamin D3 receptor | 0 | 1 | 1 | 2 |
| Transporter | 0 | 1 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 4 | 0 | 4 |
| Vitamin D3 receptor A | 0 | 0 | 2 | 2 |
| Luciferase | 2 | 0 | 0 | 2 |
| acetylcholinesterase | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
| RAR-related orphan receptor gamma | 3 | 0 | 0 | 3 |
| progesterone receptor | 4 | 0 | 0 | 4 |
| retinoic acid nuclear receptor alpha variant 1 | 3 | 0 | 0 | 3 |
| retinoid X nuclear receptor alpha | 3 | 0 | 0 | 3 |
| estrogen-related nuclear receptor alpha | 5 | 0 | 0 | 5 |
| aryl hydrocarbon receptor | 3 | 0 | 0 | 3 |
| activating transcription factor 6 | 1 | 0 | 0 | 1 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 4 | 0 | 0 | 4 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 5 | 0 | 0 | 5 |
| Voltage-dependent calcium channel gamma-2 subunit | 1 | 0 | 0 | 1 |
| Glutamate receptor 2 | 1 | 0 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
| phosphopantetheinyl transferase | 3 | 0 | 0 | 3 |
| GLI family zinc finger 3 | 1 | 0 | 0 | 1 |
| aldehyde dehydrogenase 1 family, member A1 | 2 | 0 | 0 | 2 |
| estrogen receptor 2 (ER beta) | 1 | 0 | 0 | 1 |
| nuclear receptor subfamily 1, group I, member 3 | 3 | 0 | 0 | 3 |
| farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
| Histone H2A.x | 1 | 0 | 0 | 1 |
| heat shock protein beta-1 | 1 | 0 | 0 | 1 |
| survival motor neuron protein isoform d | 1 | 0 | 0 | 1 |
| lamin isoform A-delta10 | 5 | 0 | 0 | 5 |
| Polyphenol oxidase 2 | 0 | 2 | 0 | 3 |
| Bile salt export pump | 0 | 2 | 0 | 2 |
| Dopamine beta-hydroxylase | 0 | 2 | 0 | 2 |
| Lactoperoxidase | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 1 | 1 | 3 |
| arylsulfatase A | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 2 | 3 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Beta-2 adrenergic receptor | 0 | 2 | 1 | 3 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 1 | 2 |
| Adenosine receptor A3 | 0 | 1 | 1 | 2 |
| Beta-2 adrenergic receptor | 0 | 2 | 0 | 3 |
| Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 1 | 1 | 2 |
| Beta-3 adrenergic receptor | 0 | 2 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 2 | 3 |
| Alpha-1B adrenergic receptor | 0 | 1 | 1 | 2 |
| Beta-1 adrenergic receptor | 0 | 2 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 2 | 3 |
| Muscarinic acetylcholine receptor M3 | 0 | 1 | 1 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 2 | 3 |
| Alpha-1D adrenergic receptor | 0 | 1 | 1 | 2 |
| Endothelin-1 receptor | 0 | 1 | 1 | 2 |
| Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1B | 0 | 2 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 2 | 3 |
| Adenosine receptor A2a | 0 | 1 | 1 | 2 |
| Neuromedin-K receptor | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 2 | 3 |
| Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
| Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
| Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 1 | 2 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 2 | 4 |
| Alpha-1B adrenergic receptor | 0 | 0 | 1 | 2 |
| Mu-type opioid receptor | 0 | 1 | 1 | 2 |
| Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
| Delta-type opioid receptor | 0 | 1 | 1 | 2 |
| Kappa-type opioid receptor | 0 | 1 | 1 | 2 |
| Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 2 | 3 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 1 | 3 |
| GABA theta subunit | 0 | 1 | 2 | 3 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 2 | 3 |
| Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
| interleukin 8 | 1 | 0 | 0 | 1 |
| thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
| EWS/FLI fusion protein | 2 | 0 | 0 | 2 |
| peroxisome proliferator-activated receptor delta | 2 | 0 | 0 | 2 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 1 | 0 | 0 | 1 |
| cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
| NADH-cytochrome b5 reductase 3 | 0 | 1 | 0 | 1 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Thyroid peroxidase | 0 | 1 | 0 | 1 |
| Taste receptor type 2 member 38 | 0 | 0 | 1 | 2 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 2 | 2 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 2 | 2 |
| apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform a | 2 | 0 | 0 | 2 |
| serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
| DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
| DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 3 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 2 |
| Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
| Transthyretin | 0 | 1 | 0 | 3 |
| Thyroid hormone receptor alpha | 0 | 2 | 3 | 5 |
| Thyroid hormone receptor beta | 0 | 2 | 3 | 5 |
| Proliferating cell nuclear antigen | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 4 | 4 |
| Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 2 |
| Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
| Bile acid receptor | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 0 | 0 | 2 |
| glp-1 receptor, partial | 1 | 0 | 0 | 1 |
| glucocerebrosidase | 1 | 0 | 0 | 1 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
| muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
| neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
| Prothrombin | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 4A1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |